New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - chlorpromazine hydrochloride 25 mg/ml - solution for injection - 25 mg/ml - active: chlorpromazine hydrochloride 25 mg/ml excipient: sodium chloride sodium citrate dihydrate sodium metabisulfite sodium sulfite water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - chlorpromazine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: sodium sulfite; sodium metabisulfite; sodium citrate dihydrate; water for injections; sodium chloride - 1. treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. long-term treatment of schizophrenia. 3. short-term treatment of agitation and severe depression. 4. severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. in the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. control of intractable hiccough.

Ireland - English - HPRA (Health Products Regulatory Authority)

may & baker limited - chlorpromazine hydrochloride - solution for injection - 25 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

may & baker limited - chlorpromazine hydrochloride - solution for injection - 25 mg/ml

Malta - English - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - chlorpromazine hydrochloride - solution for injection - chlorpromazine hydrochloride 25 mg/ml - psycholeptics

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - chlorpromazine hydrochloride - solution for injection - 25mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - chlorpromazine hydrochloride 25mg - tablet - 25 mg - active: chlorpromazine hydrochloride 25mg excipient: colloidal silicon dioxide hypromellose lactose monohydrate macrogol 200 magnesium stearate maize starch opaspray white m-1-7111b purified water  

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - levomepromazine hydrochloride 25 mg/ml equivalent to 22.5 mg/ml levomepromazine base;   - solution for injection - 25 mg/ml - active: levomepromazine hydrochloride 25 mg/ml equivalent to 22.5 mg/ml levomepromazine base   excipient: ascorbic acid sodium chloride sodium sulfite water for injection - nozinan is indicated in the management of terminal pain and accompanying restlessness or distress.

Malta - English - Medicines Authority

central procurement & supplies unit - chlorpromazine hydrochloride - solution for injection - chlorpromazine hydrochloride 25 milligram(s)/millilitre - psycholeptics

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - chlorpromazine hydrochloride, quantity: 5 mg/ml - oral liquid - excipient ingredients: sucrose; caramel; peppermint oil; spearmint oil; polysorbate 20; purified water; citric acid; sodium citrate dihydrate; ascorbic acid; sodium sulfite; sodium metabisulfite; sodium benzoate; flavour - 1. treatment of acute functional psychosis (eg schizophrenia, mania or psychotic depression). 2. long-term treatment of schizophrenia. 3. short-term treatment of agitation and severe depression. 4. severe behavioural disturbances, as can be found in some children with mental retardation or autism, including the treatment of self-injurious and aggressive behaviour or overactivity. use of chlorpromazine should be in conjunction with an appropriate non-pharmacological management program and long-term use should only be carried out under the supervision of a physician experienced in the management of psychotic disorders in children. 5. in the management of terminal illness to enhance the effect of analgesics and to control nausea and vomiting. 6. control of intractable hiccough.